Register Cart 0

Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back Subscribe

Editorial [Hot Topic: New Potential Pharmaceutical Targets of Metabolic Syndrome (Executive Editors: Gianluca Iacobellis and Giuseppe Barbaro)]

Author(s): Gianluca Iacobellis and Giuseppe Barbaro

Volume 13, Issue 21, 2007

Page: [2146 - 2147] Pages: 2

DOI: 10.2174/138161207781039607

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

14

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization
Current Drug Delivery

Atherosclerotic Coronary Heart Disease Epidemiology, Classification and Management
Cardiovascular & Hematological Disorders-Drug Targets

The Modern Spectrum of Rhabdomyolysis: Drug Toxicity Revealed by Creatine Kinase Screening
Current Drug Safety

The use of nanocarriers in acute myeloid leukaemia therapy: challenges and current status.
Current Pharmaceutical Biotechnology

Mesenchymal Stromal Cells from Umbilical Cord Blood
Current Stem Cell Research & Therapy

Engineered E. coli as Vehicles for Targeted Therapeutics
Current Gene Therapy

The Pharmacological Management of Intrahepatic Cholestasis of Pregnancy
Current Clinical Pharmacology

The Impact of Hypothermia on the Pharmacokinetics of Drugs Used in Neonates and Young Infants
Current Pharmaceutical Design

Drug Metabolism and Pharmacokinetic Diversity of Ranunculaceae Medicinal Compounds
Current Drug Metabolism

PiWi RNA in Neurodevelopment and Neurodegenerative Disorders
Current Molecular Pharmacology

Gene Transfer for Inherited Metabolic Disorders of the Liver: Immunological Challenges
Current Pharmaceutical Design

The Therapeutic use of the Zonulin Inhibitor AT-1001 (Larazotide) for a Variety of Acute and Chronic Inflammatory Diseases
Current Medicinal Chemistry

Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Current Medicinal Chemistry - Anti-Cancer Agents

Aquaporins in Sensory and Pain Transmission
Current Neuropharmacology

Targeting the Acute Myeloid Leukemia Stem Cells
Anti-Cancer Agents in Medicinal Chemistry

Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design

Zinc Homeostasis-regulating Proteins: New Drug Targets for Triggering Cell Fate
Current Drug Targets

Relationship Between Inflammation, Insulin Resistance and Type 2 Diabetes: Cause or Effect?
Current Diabetes Reviews

Novel Immunosuppressive Strategies for Bone Marrow Failure Syndromes: A Focus on Alemtuzumab
Mini-Reviews in Medicinal Chemistry

Herb-Drug Interactions and Mechanistic and Clinical Considerations
Current Drug Metabolism

© 2024 Bentham Science Publishers | Privacy Policy